Skip to Main Content

Paper Details

Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens.
Front Immunol
12
2021
cancer, patients, tumor, tumors
Author NameAffiliation
Jeffrey R WhiteakerClinical Research Division, Fred Hutchinson Cancer Research Center
Lei ZhaoClinical Research Division, Fred Hutchinson Cancer Research Center
Regine M SchoenherrClinical Research Division, Fred Hutchinson Cancer Research Center
Jacob J KennedyClinical Research Division, Fred Hutchinson Cancer Research Center
Chenwei LinClinical Research Division, Fred Hutchinson Cancer Research Center
Chenwei LinClinical Research Division, Fred Hutchinson Cancer Research Center
Mathangi ThiagarajanFrederick National Laboratory for Cancer Research
Stephen M HewittCenter for Cancer Research, National Cancer Institute, National Institute of Health
Stephen M HewittCenter for Cancer Research, National Cancer Institute, National Institute of Health
Emily S BojaOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Emily S BojaOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Tara HiltkeOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Tara HiltkeOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Henry RodriguezOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Henry RodriguezOffice of Cancer Clinical Proteomics Research, National Cancer Institute
Amanda G PaulovichClinical Research Division, Fred Hutchinson Cancer Research Center
  • 1 - 16

Datasets